drugset
drugset / Trial / NCT07669402

Comparative Evaluation of the Efficacy of Letrozole, L-Carnitine, and Their Combination on Sperm Quality, Oxidative Stress, and ART Outcomes in Men With Idiopathic Oligoasthenoteratozoospermia.

NCT07669402 ↗

Phase 2/3 Completed 90 enrolled Tehran University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized clinical trial evaluating the efficacy of Letrozole, L-Carnitine, and their combination on sperm quality, oxidative stress, and ART outcomes in men with idiopathic oligoasthenoteratozoospermia.

Timeline

Start
2023-12-01
Primary completion
2026-02-28
Completion
2026-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified 1000 mg Oral
Subject Letrozole Other / unclassified 2.5 mg Oral

Indications

oligoasthenoteratozoospermia